'Miracle' weight-loss drugs could have reduced health disparities: Instead they got worse
The American Heart Association calls them "game changers."
23 hours ago
0
1
The American Heart Association calls them "game changers."
23 hours ago
0
1
A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ.
Apr 20, 2024
0
0
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson's disease treatments.
Apr 17, 2024
0
76
Africa is experiencing unprecedented growth in terms of both population and economic transformation.
Apr 16, 2024
0
0
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease ...
Apr 5, 2024
0
51
Drug targets with human genetic evidence are more likely than those without to be clinically translatable and thus enter phase II/III clinical trials or be approved for marketing more quickly, which will likely significantly ...
Mar 26, 2024
0
0
A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget.
Mar 25, 2024
0
0
Gastric cancer ranks among the most widespread diseases in Asian populations, with South Koreans experiencing the third-highest incidence globally in 2020, as reported by the International Agency for Research on Cancer.
Mar 21, 2024
0
0
Individual patients with autoimmune diseases can receive tailored medication by computationally treating their so-called digital twins with thousands of medications.
Mar 20, 2024
0
0
In a recently published review in the journal Biomarker Research, Joanna Zawacka, Docent at the department of Oncology-Pathology discusses our current understanding of p53 biology in myelodysplastic syndrome (MDS) and acute ...
Mar 20, 2024
0
0